Lithium is mainly excreted into urine, and a large fraction of lithium filtered through glomeruli is reabsorbed in the proximal tubule. However, the mechanisms responsible for lithium reabsorption remain unclear. We previously reported that the reabsorption of lithium was biphasic in rats, and that foscarnet inhibited lithium reabsorption with a high affinity type. We herein evaluated the effects of acetazolamide and foscarnet on the renal excretion of lithium in rats treated with lithium chloride at 2 doses. In rats intravenously injected with a bolus of 25 mg/kg lithium chloride, acetazolamide facilitated the urinary excretion of lithium, and increased the fractional excretion of lithium from 0.446 to 0.953, near the theoretically maximum value. At a dose of 2.5 mg/kg lithium chloride, the fractional excretion of lithium was 0.241 in control rats, 0.420 in rats administered acetazolamide, and 0.976 in rats administered acetazolamide and foscarnet. These results showed the potent inhibition of lithium reabsorption by acetazolamide and foscarnet in rats. And, it was exhibited that the effects of acetazolamide on lithium reabsorption differed with the dosages of lithium administered.

Department of Pharmaceutics School of Pharmacy Aichi Gakuin University Kusumoto Chikusa Nagoya Japan

Zobrazit více v PubMed

BIBER J, HERNANDO N, FORSTER I. Phosphate transporters and their function. Annu Rev Physiol. 2013;75:535–550. doi: 10.1146/annurev-physiol-030212-183748. PubMed DOI

de GROOT T, SINKE AP, KORTENOEVEN ML, ALSADY M, BAUMGARTEN R, DEVUYST O, LOFFING J, WETZELS JF, DEEN PM. Acetazolamide attenuates lithium-induced nephrogenic diabetes insipidus. J Am Soc Nephrol. 2016;27:2082–2091. doi: 10.1681/ASN.2015070796. PubMed DOI PMC

FENVES AZ, EMMETT M, WHITE MG. Lithium intoxication associated with acute renal failure. South Med J. 1984;77:1472–1474. doi: 10.1097/00007611-198411000-00030. PubMed DOI

FINLEY PR. Drug interactions with lithium: an update. Clin Pharmacokinet. 2016;55:925–941. doi: 10.1007/s40262-016-0370-y. PubMed DOI

FINLEY PR, WARNER MD, PEABODY CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet. 1995;29:172–191. doi: 10.2165/00003088-199529030-00004. PubMed DOI

FORSTER I, HERNANDO N, BIBER J, MURER H. The voltage dependence of a cloned mammalian renal type II Na+/Pi cotransporter (NaPi-2) J Gen Physiol. 1998;112:1–18. doi: 10.1085/jgp.112.1.1. PubMed DOI PMC

FRANSEN R, BOER WH, BOER P, DORHOUT MEES EJ, KOOMANS HA. Effects of furosemide or acetazolamide infusion on renal handling of lithium: a micropuncture study in rats. Am J Physiol. 1993;264:R129–R134. doi: 10.1152/ajpregu.1993.264.1.R129. PubMed DOI

GADALLAH MF, FEINSTEIN EI, MASSRY SG. Lithium intoxication: clinical course and therapeutic considerations. Miner Electrolyte Metab. 1988;14:146–149. PubMed

GHEZZI C, MURER H, FORSTER IC. Substrate interactions of the electroneutral Na+-coupled inorganic phosphate cotransporter (NaPi-IIc) J Physiol. 2009;17:4293–4307. doi: 10.1113/jphysiol.2009.175596. PubMed DOI PMC

KORTENOEVEN ML, LI Y, SHAW S, GAEGGELER HP, ROSSIER BC, WETZELS JF, DEEN PM. Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney Int. 2009;76:44–53. doi: 10.1038/ki.2009.91. PubMed DOI

KRISHNAN D, LIU L, WIEBE SA, CASEY JR, CORDAT E, ALEXANDER RT. Carbonic anhydrase II binds to and increases the activity of the epithelial sodium-proton exchanger, NHE3. Am J Physiol Renal Physiol. 2015;309:F383–F392. doi: 10.1152/ajprenal.00464.2014. PubMed DOI PMC

LEBLANC M, RAYMOND M, BONNARDEAUX A, ISENRING P, PICHETTE V, GEADAH D, QUIMET D, ETHIER J, CARDINAL J. Lithium poisoning treated by high-performance continuous arteriovenous and venovenous hemodiafiltration. Am J Kidney Dis. 1996;27:365–372. doi: 10.1016/S0272-6386(96)90359-5. PubMed DOI

PRICE LH, HENINGER GR. Lithium in the treatment of mood disorders. N Engl J Med. 1994;331:591–598. doi: 10.1056/NEJM199409013310907. PubMed DOI

STEELE TH, DUDGEON KL, LARMORE CK. Pharmacological characterization of lithium reabsorption in the rat. J Pharmacol Exp Ther. 1976;196:188–193. PubMed

THOMAS L, XUE J, DOMINGUEZ RIEG JA, RIEG T. Contribution of NHE3 and dietary phosphate to lithium pharmacokinetics. Eur J Pharm Sci. 2019;128:1–7. doi: 10.1016/j.ejps.2018.11.008. PubMed DOI PMC

THOMSEN K, SCHOU M. Renal lithium excretion in man. Am J Physiol. 1968;215:823–827. doi: 10.1152/ajplegacy.1968.215.4.823. PubMed DOI

TIMMER RT, SANDS JM. Lithium intoxication. J Am Soc Nephrol. 1999;10:666–674. PubMed

UWAI Y, ARIMA R, TAKATSU C, FURUTA R, KAWASAKI T, NABEKURA T. Sodium-phosphate cotransporter mediates reabsorption of lithium in rat kidney. Pharmacol Res. 2014;87:94–98. doi: 10.1016/j.phrs.2014.06.012. PubMed DOI

UWAI Y, KAWASAKI T, NABEKURA T. Nonlinear disposition of lithium in rats and saturation of its tubular reabsorption by the sodium-phosphate cotransporter as a cause. Biopharm Drug Dispos. 2018;39:83–87. doi: 10.1002/bdd.2116. PubMed DOI

VALLON V, RIEG T. Regulation of renal NaCl and water transport by the ATP/UTP/P2Y2 receptor system. Am J Physiol Renal Physiol. 2011;301:F463–F475. doi: 10.1152/ajprenal.00236.2011. PubMed DOI PMC

VILLA-BELLOSTA R, BOGAERT YE, LEVI M, SORRIBAS V. Characterization of phosphate transport in a rat vascular smooth muscle cells: implications for vascular calcification. Arterioscler Thromb Vasc Biol. 2007;27:1030–1036. doi: 10.1161/ATVBAHA.106.132266. PubMed DOI

YUKAWA E, NOMIYAMA N, HIGUCHI S, AOYAMA T. Lithium population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens. Ther Drug Monit. 1993;15:75–82. doi: 10.1097/00007691-199304000-00002. PubMed DOI

ZHANG Y, NORIAN JM, MAGYAR CE, HOLSTEIN-RATHLOU NH, MIRCHEFF AK, McDONOUGH AA. In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibition. Am J Physiol. 1999;276:F711–F719. doi: 10.1152/ajprenal.1999.276.5.F711. PubMed DOI

Analysis of sex difference in the tubular reabsorption of lithium in rats